glp-1 treatment kenner therapy GLP-1s are not “making people in larger bodies feel like thin people.” That framing oversimplifies human biology and can worsen weight stigma by implying certain bodies deserve less nourishment GLP-1 & Microdosing | AgelessRx

This treatment is generally aimed at improving skin texture and promoting a younger look

Book your consultation today and lets map out your perfect lip shape together

Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: A meta-analysis of randomised controlled trials

46 That dedicated kidney outcomes study, involving over 3500 patients with both T2D and established chronic kidney disease, demonstrated that once-weekly subcutaneous semaglutide 1.0 mg significantly reduced the primary composite renal outcome (including kidney failure onset, a 50% persistent decline in estimated glomerular filtration rate (eGFR), or renal/cardiovascular death) compared with placebo